Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers

Clinical trial NCT05835804 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05835804
Sponsor: Centre Hospitalier Universitaire, Amiens
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Paclitaxel Carboplatin Nivolumab

Start date: 2025-11-01
Primary completion: 2026-04-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.